Life expectancy of people with HIV on antiretroviral therapy in Spain
Inmaculada Jarrín, Antonio Rivero(Hospital Universitario Reina Sofía), Javier Martínez‐Sanz(Instituto Cajal), José Ramón Blanco, Marta Rava(Instituto de Salud Carlos III), María Lagarde(Instituto de Salud Carlos III), Jorge del Romero Raposo(Centro Nacional de Epidemiología), David Dalmau(University Hospital Mútua de Terrassa), Gemma Navarro(Corporació Sanitària Parc Taulí), Julia del Amo(Government of Spain), Ana Koerting(Government of Spain), Javier Gomez Castell(Government of Spain)
Cited by 24
Related Papers
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137
A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)
|Antiviral Therapy|2002|137
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study
|Clinical Microbiology and Infection|2020|108
Fecal microbiota transplantation in HIV: A pilot placebo-controlled study
|Nature Communications|2021|94